Orchestra BioMed Holdings, Inc.
OBIO
$4.49
-$0.08-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.25M | -20.83M | -19.36M | -18.76M | -16.16M |
| Total Depreciation and Amortization | 82.00K | 81.00K | 81.00K | 83.00K | 84.00K |
| Total Amortization of Deferred Charges | 64.00K | 59.00K | 46.00K | 46.00K | 31.00K |
| Total Other Non-Cash Items | 3.62M | 3.60M | 3.35M | 3.00M | 3.87M |
| Change in Net Operating Assets | -12.28M | 2.54M | 358.00K | -990.00K | -1.36M |
| Cash from Operations | -2.27M | -14.55M | -15.53M | -16.62M | -13.54M |
| Capital Expenditure | -33.00K | -310.00K | -34.00K | -112.00K | -106.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -602.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.68M | -38.27M | 16.39M | 13.11M | -3.05M |
| Cash from Investing | -17.71M | -38.58M | 16.36M | 13.00M | -3.75M |
| Total Debt Issued | 0.00 | 20.00M | -- | -- | 15.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.54M | 57.78M | 0.00 | 91.00K | 51.00K |
| Repurchase of Common Stock | -468.00K | -269.00K | -428.00K | -387.00K | -550.00K |
| Issuance of Preferred Stock | 12.56M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -972.00K | -1.11M | -- | -- | -554.00K |
| Cash from Financing | 12.66M | 76.40M | -428.00K | -296.00K | 13.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.32M | 23.26M | 401.00K | -3.91M | -3.34M |